Envestnet Asset Management Inc. Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Envestnet Asset Management Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,139,887 shares of the healthcare conglomerate's stock after selling 51,150 shares during the quarter. Envestnet Asset Management Inc. owned 0.23% of UnitedHealth Group worth $1,082,483,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at about $341,000. Principal Financial Group Inc. raised its stake in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after buying an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $319,000. Texas Capital Bank Wealth Management Services Inc raised its stake in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,370 shares of the healthcare conglomerate's stock valued at $9,571,000 after purchasing an additional 236 shares during the period. Finally, Temasek Holdings Private Ltd boosted its position in shares of UnitedHealth Group by 137.6% in the third quarter. Temasek Holdings Private Ltd now owns 161,656 shares of the healthcare conglomerate's stock valued at $94,517,000 after acquiring an additional 93,618 shares during the period. Institutional investors own 87.86% of the company's stock.

Remove Ads

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Up 2.5 %

UnitedHealth Group stock traded up $14.09 during midday trading on Wednesday, hitting $567.17. 4,595,211 shares of the company's stock were exchanged, compared to its average volume of 4,299,407. The firm has a 50-day moving average of $509.40 and a two-hundred day moving average of $541.42. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market cap of $518.80 billion, a PE ratio of 36.60, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.48%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on UNH shares. KeyCorp reissued an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty-one analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $630.35.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.